RT @BrianC_Miller: Excited that our new paper just got published online. https://t.co/kF6E5roWJM. Thanks to all of our co-authors who contr…
RT @3DiMMUNE: it appears there are now ‘progenitor exhausted’ and ‘terminally exhausted’ TIL CD8 cells. Feels like scientists are competing…
RT @BrianC_Miller: Excited that our new paper just got published online. https://t.co/kF6E5roWJM. Thanks to all of our co-authors who contr…
RT @Immunoscope: Progenitor (rather than terminally) exhausted CD8+ T cells respond to anti-PD-1 therapy and control tumor growth | #Cancer…
RT @BrianC_Miller: Excited that our new paper just got published online. https://t.co/kF6E5roWJM. Thanks to all of our co-authors who contr…
RT @DrChoueiri: @nickhaining continues his high quality #immunology #collaborative work here with this @NatImmunol paper with Steve Hodi, A…
RT @DrChoueiri: @nickhaining continues his high quality #immunology #collaborative work here with this @NatImmunol paper with Steve Hodi, A…
RT @Immunoscope: Progenitor (rather than terminally) exhausted CD8+ T cells respond to anti-PD-1 therapy and control tumor growth | #Cancer…
RT @AuclairDan: Subsets of exhausted CD8 + #Tcells differentially mediate #tumor control and respond to #checkpoint blockade https://t.co/S…
RT @DrChoueiri: @nickhaining continues his high quality #immunology #collaborative work here with this @NatImmunol paper with Steve Hodi, A…
@nickhaining continues his high quality #immunology #collaborative work here with this @NatImmunol paper with Steve Hodi, Arlene Sharpe, Scott Rodig and many others ! #TeamScience @DanaFarber https://t.co/848hHX19ZP
Subsets of exhausted CD8 + #Tcells differentially mediate #tumor control and respond to #checkpoint blockade https://t.co/S8OlkbfCz8
Amazing work! Nice to see it in one piece after talking to you about it for a while.
RT @Immunoscope: Progenitor (rather than terminally) exhausted CD8+ T cells respond to anti-PD-1 therapy and control tumor growth | #Cancer…
Many Congratulations @BrianC_Miller
RT @Immunoscope: Progenitor (rather than terminally) exhausted CD8+ T cells respond to anti-PD-1 therapy and control tumor growth | #Cancer…
RT @Immunoscope: Progenitor (rather than terminally) exhausted CD8+ T cells respond to anti-PD-1 therapy and control tumor growth | #Cancer…
it appears there are now ‘progenitor exhausted’ and ‘terminally exhausted’ TIL CD8 cells. Feels like scientists are competing in coming up with new terms rather than mechanisms of fate decisions that must be, imo, Ag-specific in nature. https://t.co/siQ
RT @BrianC_Miller: Excited that our new paper just got published online. https://t.co/kF6E5roWJM. Thanks to all of our co-authors who contr…
another cool story from @BrianC_Miller @DebattamaSen and @nickhaining
RT @Immunoscope: Progenitor (rather than terminally) exhausted CD8+ T cells respond to anti-PD-1 therapy and control tumor growth | #Cancer…
RT @Immunoscope: Progenitor (rather than terminally) exhausted CD8+ T cells respond to anti-PD-1 therapy and control tumor growth | #Cancer…
Progenitor (rather than terminally) exhausted CD8+ T cells respond to anti-PD-1 therapy and control tumor growth | #Cancer #Immunotherapy #PD1 #CD8Tcells #exhaustion | Nick Haining @nickhaining @DanaFarber @broadinstitute | Nature Immunology @NatImmunol ht
Excited that our new paper just got published online. https://t.co/kF6E5roWJM. Thanks to all of our co-authors who contributed, especially @DebattamaSen, Rose Al Abosy, and Kevin Bi, and of course @nickhaining